Expansion Opportunity WEP Clinical is growing footprint with new London office and Northern Europe presence, signaling readiness for more European trials and EAPs. This creates opportunities to cross-sell expanded access programs, post-approval patient access, and site-led trial management services to sponsors expanding in Europe.

Acquisition Momentum Recent acquisition of Siron Clinical broadens European operations and flexible clinical services, enabling leverage of combined networks for faster site activation and diverse trial operations—a compelling angle for sponsors seeking scale in Europe without onboarding friction.

Nursing Excellence Expansion of Clinical Trial Home Nursing and appointment of a Head of Clinical Nursing Operations demonstrates strength in decentralized and on-site nursing support, presenting upsell for mobile research nursing, EAPs, and named patient programs to sponsors prioritizing patient-centric, real-time data collection.

Access Programs Active design and execution of Expanded Access Programs, Named Patient Programs, and post-approval access initiatives across multiple countries highlight WEP Clinical as a mature partner for sponsors needing regulatory-aligned pathways to patient access, potentially expanding revenue from EAPs and market access solutions.

European Market Depth New UK office, European operations, and partnerships in EU/EEA contexts position WEP Clinical to engage sponsors targeting Europe’s diverse regulatory landscapes, offering end-to-end trial operations, market access, and patient access programs to accelerate global trials.